Barinthus Biotherapeutics Plc. - ADR Live Share Price Today, Share Analysis and Chart

Name: Barinthus Biotherapeutics Plc. - ADR: Is Infosys Ltd. worth buying?
Item: Barinthus Biotherapeutics Plc. - ADR
Rating: 1.85575
Author: Trendlyne DVM scores

about

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment...

1.00 -0.06 (-5.66%)

36.71% Fall from 52W High

3,672

XNAS Volume

High vol. this week

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

27.5 / 100

Technically Neutral

46.7 / 100

1Yr Price target upside is 350%

2 analysts

Barinthus Biotherapeutics ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Barinthus Biotherapeutics Plc. - ADR Live Share Price Today, Share Analysis and Chart

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment...

36.71% Fall from 52W High

High vol. this week

SWOT Analysis

Barinthus Biotherapeutics ... Live Price Chart